The prevalence of obesity in America is a significant health concern, with approximately 42% of American adults classified as obese, according to the Centers for Disease Control and Prevention (CDC). This has led to increased interest in medications like Ozempic for weight loss, sparking debates about its appropriate use, insurance coverage, and long-term implications.
How Ozempic Works
Ozempic is a weekly injection designed to lower blood sugar levels by stimulating the pancreas to produce more insulin. It contains the active ingredient semaglutide, which mimics a naturally occurring hormone known as glucagon-like peptide-1 (GLP-1). As hormone levels rise, the molecules go to your brain, telling it you're full. It also slows digestion by increasing the time it takes for food to leave the body. While Ozempic is approved for treating type 2 diabetes, weight loss is often observed as a side effect.
Ozempic vs. Wegovy: What's the Difference?
While Ozempic is not explicitly approved for weight loss, semaglutide, its active ingredient, is approved for weight loss under the brand name Wegovy. Both medications are manufactured by the same company and contain semaglutide. However, Wegovy contains higher doses of semaglutide and is specifically designed for chronic weight management.
Benefits of Semaglutide Treatments
Research indicates that semaglutide treatments, such as Ozempic and Wegovy, can effectively promote weight loss, which can reduce the risk of serious health conditions like heart problems. For some patients with obesity, semaglutide treatments can even serve as an alternative to bariatric surgery.
The Importance of Lifestyle Changes
Anti-Obesity Medications are effective only when combined with lifestyle changes. You will be asked to keep a food log and meet with a registered dietitian as well as an exercise physiologist and in some cases a behaviorist to help initiate this.
Read also: Benefits of couples massage detailed
The Role of GLP-1s
GLP-1s are medications used to help control blood sugar levels in type 2 diabetes, but studies show it helps people without diabetes lose weight. The use of GLP-1s has been shown to be effective in helping people with type 2 diabetes lose weight. Studies have found that those using this medication can lose up to 10% of their body weight after 16 weeks of treatment. Additionally, they can help to reduce blood sugar levels and improve the body’s ability to regulate insulin. As a result, people with type 2 diabetes may find that their condition is better managed with the use of this medication. Furthermore, the use of GLP-1s can help to reduce the risk of certain complications associated with type 2 diabetes, such as heart attack and stroke. GLP-1s will also benefit you by reducing your physical hunger, helping you sleep better, give you better energy, and weight loss benefits in which you can expect to lose roughly 15% of your weight.
Cautions and Considerations
Despite the potential benefits, experts advise against using Ozempic for weight loss unless a person has type 2 diabetes. The FDA also cautions against using "generic" versions of Ozempic and Wegovy due to potential safety concerns.
A significant concern is that the body may adapt to these drugs, establishing a new normal that can lead to a weight plateau. Moreover, maintaining weight loss often requires staying on the medication long-term, which poses financial implications.
Insurance Coverage and Cost Concerns
The increasing popularity of Ozempic and similar medications has raised concerns about their cost and who should have access to them through insurance coverage. Some states, like North Carolina, have experienced significant increases in healthcare expenditures due to these drugs, leading to debates about coverage limitations.
North Carolina suffered from sticker shock as Blanchard shed pounds and thousands of others on the state insurance program - which covers more than 76,000 employees across 178 agencies, plus their dependents - tried to do the same. Ozempic and other glucagon-like peptide-1 (GPL-1) agonist medications accounted for 10% of the state employee health plan’s annual prescription drug spending, according to a North Carolina State Health Plan fact sheet. The state treasurer projected the class of drugs would cost the state more than $170 million this year, with costs jumping to more than $1 billion over the next six years.
Read also: How digestive health affects weight loss
The high prices have also raised concerns about the cost for other taxpayer-funded health care programs, such as Medicare. The Centers for Medicare & Medicaid Services estimated that coverage under the Biden proposal would cost about $40 billion over 10 years, including an extra $3.8 billion for states.
Alternative Anti-Obesity Medications
Besides semaglutide-based medications, several other options are available for weight management. These include:
- Tirzepatide (Zepbound): A pharmaceutical-grade weight loss supplement that suppresses appetite and promotes feelings of fullness.
- Liraglutide (Victoza, Saxenda): A GLP-1 receptor agonist used for both type 2 diabetes and weight management.
- Phentermine: A medication primarily used for short-term weight loss in individuals who are overweight or obese.
- Topiramate: An anticonvulsant medication used to treat epilepsy and prevent migraines.
- Qsymia: Typically prescribed as part of a comprehensive weight loss program that includes dietary modifications and increased physical activity. Food and Drug Administration (FDA) for chronic weight management in adults who are overweight or obese.
- Bupropion and Naltrexone (Contrave): An antidepressant and opioid addiction medication, respectively, combined for weight management.
Grand Health Partners and Semaglutide
At Grand Health Partners, we are proud to prescribe Semaglutide in Grand Rapids and surrounding areas. Semaglutide, otherwise known as Wegovy, is a cutting-edge, FDA-approved medication that supports chronic weight management in adults with obesity or those with weight-related conditions and health risks. Semaglutide is a GLP-1 receptor agonist that’s similar to in cretin, a naturally-occurring hormone that controls your appetite. As such, the semaglutide medication can control your appetite and prevent hunger pangs, thus supporting your weight loss goals. Semaglutide is a one-of-a-kind drug only meant for individuals who are overweight or obese, i.e., those with a BMI of 27 or more and have a weight-related condition, such as diabetes, or those with a BMI of 30 or more. Tirzepatide, also known Zepbound prescribed at Grand Health Partners, serves as a pharmaceutical-grade weight loss supplement renowned for its appetite-suppressing effects, facilitating a sensation of fullness quicker and for extended durations. By leveraging this precise mechanism, Tirzepatide effectively induces feelings of satiety, alleviating hunger pangs. In addition to decreasing your appetite, Tirzepatide in Grand Rapids can also slow down the digestive processes within your stomach. This medication makes your stomach empty out slower, so you continue feeling sated long after your meals, preventing you from snacking between meals. Tirzepatide is a one-of-a-kind drug only meant for individuals who are overweight or obese, i.e., those with a BMI of 27 or more and have a weight-related condition, such as diabetes, or those with a BMI of 30 or more. Liraglutide in Grand Rapids, Michigan is a medication that belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It is used primarily for the treatment of type 2 diabetes mellitus. In addition to its use in diabetes management, liraglutide has also been approved for weight management in certain individuals who have obesity or who are overweight and have weight-related complications. Liraglutide is typically administered via subcutaneous injection and is marketed under the brand name Victoza for diabetes treatment and Saxenda for weight management.
Overcoming Barriers to Access
Dr. Nishant Shah emphasizes the need to eliminate hurdles in the healthcare system that make it difficult to obtain these drugs. Besides making the medication more affordable, he said, it should encourage the use of weight loss drugs and treatment of obesity as a chronic disease instead of stigmatizing it as a moral failing. Family medicine physician Dr. Melissa Jones of Charlotte said she has often seen a bias against people in her weight management practice when they try to get these medications covered by private insurance.
Read also: Weight Loss Meds & BCBS